• NLRP10 Regulates Epidermal Homeostasis in Atopic Dermatitis

  2026-05-27

  The reference study identifies NLRP10 as a critical regulator of epidermal barrier integrity and keratinocyte differentiation, directly linking its downregulation to atopic dermatitis (AD) pathology. These findings clarify the molecular underpinnings of skin barrier dysfunction in AD and suggest NLRP10 as a promising therapeutic target for restoring skin homeostasis.

• Chenodeoxycholic Acid: FXR Activation in Renal & Metabolic R

  2026-05-27

  Chenodeoxycholic Acid (CDCA) serves as a potent FXR agonist central to cholesterol metabolism research and nuclear receptor signaling. Recent evidence establishes CDCA’s ability to protect renal tissue by activating the FXR-KLF11 axis and suppressing JAK2/STAT3-mediated inflammation, positioning it as a valuable tool for metabolic and kidney injury models.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1 En

  2026-05-26

  Cheng et al. identify fangchinoline as a potent modulator of lysosomal biogenesis, acting via TFEB activation to restore lysosomal integrity and block H1N1 influenza virus entry. This study highlights the therapeutic potential of targeting host lysosomal pathways for antiviral intervention and provides a framework for future research into lysosome-focused drug development.

• Fludarabine (SKU A5424): Data-Backed Solutions for Oncology

  2026-05-26

  This article provides practical, scenario-driven guidance for leveraging Fludarabine (SKU A5424) as a DNA synthesis inhibitor in cell viability, proliferation, and apoptosis assays. Drawing on peer-reviewed research and product documentation, it addresses common workflow challenges and demonstrates how APExBIO’s Fludarabine ensures reproducibility and data integrity in leukemia and multiple myeloma research.

• TAK1-YAP Signaling Drives Self-Renewal in Gastric Cancer Ste

  2026-05-25

  This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), promoting the self-renewal and oncogenicity of gastric cancer stem cells (GCSCs). The findings clarify a novel molecular axis with implications for targeting chemoresistance and recurrence in gastric cancer.

• Pterostilbene Enhances Mitophagy to Delay Dermal Fibroblast

  2026-05-25

  Zhou et al. (2025) demonstrate that pterostilbene delays senescence in human dermal fibroblasts by enhancing mitochondrial quality through increased mitophagy. These findings advance the mechanistic understanding of skin aging and highlight mitochondrial quality control as a promising target for anti-aging interventions in skin research.

• GZMK+ CD8+ T Cells Drive Recurrent Airway Inflammation

  2026-05-24

  This study reveals that persistent GZMK-expressing CD8+ memory T cells play a central role in the recurrence of airway inflammatory diseases, such as chronic rhinosinusitis with nasal polyps. By integrating TCR repertoire sequencing and functional experiments, the research pinpoints GZMK and complement activation as key mediators, establishing new mechanistic targets for disease intervention.

• Nitrocefin: Precision β-Lactamase Assays in Modern Resistanc

  2026-05-23

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, enables robust, high-resolution β-lactamase enzymatic activity measurement. This article delivers a unique, research-driven analysis connecting molecular mechanism, emerging resistance trends, and real-world assay optimization.

• Optimizing Cancer Assays with Cyclo (-RGDfC): Practical Solu

  2026-05-22

  This article addresses laboratory challenges in cell viability and tumor targeting by leveraging Cyclo (-RGDfC) (SKU A8790), a high-purity cyclic RGD peptide designed for αvβ3 integrin research. It delivers scenario-driven guidance rooted in real-world assay needs, ensuring reproducibility and actionable insight for biomedical researchers.

• Neticonazole Hydrochloride: Dual-Action Antifungal and Antit

  2026-05-22

  Explore how Neticonazole Hydrochloride, a leading imidazole antifungal, bridges infectious disease and oncology research through unique mechanisms. This in-depth article uncovers advanced applications and experimental insights not found in standard overviews.

• Lumiracoxib: Selective COX-2 Inhibitor for Research Applicat

  2026-05-21

  Lumiracoxib is a highly selective COX-2 inhibitor with a 515-fold preference over COX-1. It offers precise inhibition of cyclooxygenase-2 in inflammation and angiogenesis studies. APExBIO provides Lumiracoxib for reproducible, high-sensitivity assays in muscle injury and regeneration research.

• Metoprolol as a Selective Beta1-Adrenoceptor Antagonist in R

  2026-05-21

  Metoprolol’s precision as a selective beta1-adrenoceptor antagonist empowers researchers to unravel cardiovascular and cross-domain biological mechanisms. This guide delivers actionable workflow enhancements, protocol specifics, and troubleshooting strategies that maximize reliability in cardiovascular, anti-inflammatory, and cancer biology research.

• Danazol (Danocrine): Applied Protocols for Endocrine Modelin

  2026-05-20

  Harness Danazol’s unique inhibition of steroidogenesis for robust models of HPG axis modulation, androgen receptor signaling, and disease phenotypes. Discover workflow enhancements, troubleshooting tips, and new experimental directions grounded in both bench evidence and the latest animal model insights.

• Veratridine: Voltage-Gated Sodium Channel Opener in Cardiac

  2026-05-20

  Veratridine, a potent voltage-gated sodium channel opener, is redefining sodium channel dynamics research and chamber-specific cardiac modeling. This guide translates recent advances into actionable protocols, troubleshooting insights, and strategic applications for neuroscience and cardiac researchers.

• Virus-Mimicking Nanoparticles Enable Extrahepatic mRNA Deliv

  2026-05-19

  This study introduces a self-assembling enveloped virus-mimicking particle (EVMP) platform that achieves efficient, targeted mRNA delivery to extrahepatic organs such as the lung and spleen. By overcoming the hepatic tropism and immunogenicity issues of conventional mRNA delivery systems, the work opens new avenues for gene therapy and functional mRNA research in non-liver tissues.

16263 records 1/1085 page Next 12345 下5页 Last page